- Home
- EVAX vs CYCN Comparison
EVAX vs CYCN Comparison
Compare EVAX & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- CYCN
- Stock Information
- Founded
- EVAX 2008
- CYCN 2018
- Country
- EVAX Denmark
- CYCN United States
- Employees
- EVAX N/A
- CYCN N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- EVAX Health Care
- CYCN Health Care
- Exchange
- EVAX Nasdaq
- CYCN Nasdaq
- Market Cap
- EVAX 10.8M
- CYCN 6.5M
- IPO Year
- EVAX 2021
- CYCN N/A
- Fundamental
- Price
- EVAX $2.41
- CYCN $2.80
- Analyst Decision
- EVAX Strong Buy
- CYCN
- Analyst Count
- EVAX 2
- CYCN 0
- Target Price
- EVAX $10.00
- CYCN N/A
- AVG Volume (30 Days)
- EVAX 122.5K
- CYCN 21.8K
- Earning Date
- EVAX 08-13-2025
- CYCN 08-06-2025
- Dividend Yield
- EVAX N/A
- CYCN N/A
- EPS Growth
- EVAX N/A
- CYCN N/A
- EPS
- EVAX N/A
- CYCN N/A
- Revenue
- EVAX $3,293,000.00
- CYCN $2,081,000.00
- Revenue This Year
- EVAX N/A
- CYCN N/A
- Revenue Next Year
- EVAX N/A
- CYCN N/A
- P/E Ratio
- EVAX N/A
- CYCN N/A
- Revenue Growth
- EVAX 2555.64
- CYCN N/A
- 52 Week Low
- EVAX $1.20
- CYCN $1.27
- 52 Week High
- EVAX $17.75
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- EVAX 51.83
- CYCN 41.24
- Support Level
- EVAX $2.43
- CYCN $3.02
- Resistance Level
- EVAX $2.95
- CYCN $3.16
- Average True Range (ATR)
- EVAX 0.28
- CYCN 0.21
- MACD
- EVAX -0.05
- CYCN -0.03
- Stochastic Oscillator
- EVAX 36.65
- CYCN 16.26
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.